July 2025
1. WANG J, Zhang Z, Liu H, Wang J, et al
   Identification of Constitutional MLH1 Methylation in MLH1-Deficient Colorectal Cancer.
   Hum Pathol. 2025 Jul 26:105880. doi: 10.1016/j.humpath.2025.105880.
   

   >> Share

   
   June 2025
2. MANI P, Mehra L, Deepak R, Tiwari A, et al
   Evaluation of a novel surrogate panel for classifying human colorectal carcinomas according to consensus molecular subtypes.
   Hum Pathol. 2025;160:105840.
   

   >> Share

   
   
3. ZADA S, Aslam S, Shah S, Chandan VS, et al
   Reassessing the routine histopathological evaluation of anastomotic doughnuts in colorectal procedures: A 10-year retrospective study.
   Hum Pathol. 2025;160:105836.
   

   >> Share

   
   April 2025
4. AIJALA VK, Sirnio P, Elomaa H, Karjalainen H, et al
   Significance of mucin-suspended tumor bud-like structures in colorectal cancer.
   Hum Pathol. 2025;158:105772.
   

   >> Share

   
   March 2025
5. ZHU X, Meng X, Mochel MC, Wiliams EA, et al
   CYLD-mutated anal squamous cell carcinoma: An uncommon entity associated with cylindroma-like morphology and adverse clinical features.
   Hum Pathol. 2025;157:105765.
   

   >> Share

   
   February 2025
6. LEE SH, Pankaj A, Yilmaz O, Deshpande V, et al
   Beta-2-microglobulin positive tumor cells and CD8 positive lymphocytes are associated with outcome in post-neoadjuvant colorectal cancer resections.
   Hum Pathol. 2025;155:105737.
   

   >> Share

   
   January 2025
7. LASOTA J, Kaczorowski M, Chlopek M, Milek-Krupa J, et al
   An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapy.
   Hum Pathol. 2025;155:105717.
   

   >> Share

   
   December 2024
8. XU Z, Theisen BK, Chang Q, Schultz D, et al
   Survival outcomes of poorly differentiated colorectal carcinoma variants: Insights from a single teaching institute.
   Hum Pathol. 2024;154:105710.
   

   >> Share

   
   September 2024
9. RERKPICHAISUTH V, Lau RP, Meyerson C, Fishbein GA, et al
   The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma.
   Hum Pathol. 2024;151:105627.
   

   >> Share

   
   August 2024
10. LANSOM J, Liew I, Ng KS, Ly T, et al
    Right vs. Left Colorectal Cancer - Where Do We Draw the Line?
    Hum Pathol. 2024 Aug 6:105634. doi: 10.1016/j.humpath.2024.105634.
    

    >> Share

    
    July 2024
11. JAN YH, Lu CT, Lam AK
    Comparison of genomic profiling of patient-matched primary colorectal and surgical resected distant metastatic (stage IV) colorectal carcinoma for drug actionability.
    Hum Pathol. 2024;149:21-28.
    

    >> Share

    
    June 2024
12. CHALLA B, Frankel WL, Knight D, Pearlman R, et al
    EPM2AIP1 Immunohistochemistry Is Inadequate as A Surrogate Marker for MLH1 Promoter Hypermethylation Testing in Colorectal Cancer.
    Hum Pathol. 2024 Jun 28:S0046-8177(24)00125.
    

    >> Share

    
    March 2024
13. HO YH, Hsu CY, Yau Li AF, Liang WY, et al
    Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
    Hum Pathol. 2024;145:80-85.
    

    >> Share

    
    
14. VOS AM, Pijnenborg L, van Vliet S, Kodach LL, et al
    Biological background of colorectal polyps and carcinomas with heterotopic ossification: A national study and literature review.
    Hum Pathol. 2024;145:34-41.
    

    >> Share

    
    
15. SUGAI T, Uesugi N, Osakabe M, Yao T, et al
    Characterization of sessile serrated adenomas with dysplasia including intramucosal adenocarcinoma and colorectal carcinoma with a microsatellite instability phenotype.
    Hum Pathol. 2024;145:9-15.
    

    >> Share

    
    February 2024
16. PIHLMANN KRISTENSEN M, Korsgaard U, Timm S, Hansen TF, et al
    The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
    Hum Pathol. 2024 Feb 28:S0046-8177(24)00033.
    

    >> Share

    
    
17. OZEKI H, Shimada Y, Nakano M, Kondo S, et al
    Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer.
    Hum Pathol. 2024 Feb 27:S0046-8177(24)00032.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share